These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15043386)

  • 1. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism.
    Greenfield RA; Bronze MS
    Curr Opin Investig Drugs; 2004 Feb; 5(2):135-40. PubMed ID: 15043386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological agents: weapons of warfare and bioterrorism.
    Broussard LA
    Mol Diagn; 2001 Dec; 6(4):323-33. PubMed ID: 11774197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particulate delivery systems for biodefense subunit vaccines.
    Bramwell VW; Eyles JE; Oya Alpar H
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1247-65. PubMed ID: 15935873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Practical strategies against bioterrorism].
    Matsumoto T
    Nihon Rinsho; 2007 Dec; 65(12):2363-73. PubMed ID: 18069284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Germs employed as biological weapons].
    Meyer CG; May J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):538-46. PubMed ID: 12215940
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs and vaccines against biological weapons.
    Conn Med; 2001 Dec; 65(12):719-20. PubMed ID: 11797482
    [No Abstract]   [Full Text] [Related]  

  • 8. Recognition and management of bioterrorism infections.
    O'Brien KK; Higdon ML; Halverson JJ
    Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioterrorism: a new frontier for drug discovery and development.
    Shailubhai K
    IDrugs; 2003 Aug; 6(8):773-80. PubMed ID: 12917773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological weapons].
    Kerwat K; Becker S; Wulf H; Densow D
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1612-6. PubMed ID: 20717866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic aspects of bacterial agents.
    Martin GJ; Marty AM
    Clin Lab Med; 2001 Sep; 21(3):513-48, ix. PubMed ID: 11572140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy.
    Binder P; Attre O; Boutin JP; Cavallo JD; Debord T; Jouan A; Vidal D
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):401-21. PubMed ID: 12818625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diseases caused by bacteria and rickettsia in biological warfare and bioterrorism].
    Bojić I; Vukadinov J; Minić S
    Med Pregl; 2007; 60(3-4):195-7. PubMed ID: 17853736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients exposed to biologic weapons.
    Yetman RJ; Parks D; Taft E
    J Pediatr Health Care; 2002; 16(5):256-61. PubMed ID: 12226595
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents.
    Greenfield RA; Bronze MS
    Drug Discov Today; 2003 Oct; 8(19):881-8. PubMed ID: 14554016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulism: the many faces of botulinum toxin and its potential for bioterrorism.
    Villar RG; Elliott SP; Davenport KM
    Infect Dis Clin North Am; 2006 Jun; 20(2):313-27, ix. PubMed ID: 16762741
    [No Abstract]   [Full Text] [Related]  

  • 18. The USA preparing for bioterrorism: the role of Fort Detrick since 1970.
    Proctor RA
    WMJ; 2002; 101(2):20-4. PubMed ID: 12085492
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparedness for a bioterrorism event in Alaska. Part 1: Detection and identification of a biologic event.
    Funk EA
    Alaska Med; 2000; 42(4):101-13. PubMed ID: 14593880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA; Broussard LA
    Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.